Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab plus chemotherapy vs chemotherapy in metastatic pediatric soft tissue sarcoma
2007-005017-19Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in rhabdomyosarcoma (RMS), non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), Malignant mesenchymoma, sponsored by Roche. Started Dec 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
rhabdomyosarcoma (RMS)non-rhabdomyosarcoma soft tissue sarcoma (NRSTS)Malignant mesenchymoma
Beyond the preview
Go deeper on 2007-005017-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005017-19.